Sonova (OTCMKTS:SONVY) Stock Crosses Above 50-Day Moving Average – Here’s What Happened

Sonova Holding (OTCMKTS:SONVYGet Free Report)’s share price passed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $51.11 and traded as high as $57.92. Sonova shares last traded at $57.37, with a volume of 5,453 shares.

Analyst Ratings Changes

SONVY has been the topic of a number of recent analyst reports. Morgan Stanley raised shares of Sonova from an “underweight” rating to an “equal weight” rating in a research report on Tuesday, June 23rd. UBS Group raised shares of Sonova from a “hold” rating to a “buy” rating in a research report on Wednesday, July 22nd. Finally, Citigroup reiterated a “sell” rating on shares of Sonova in a research note on Friday, July 24th. One equities research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, three have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, Sonova presently has an average rating of “Hold”.

View Our Latest Research Report on SONVY

Sonova Trading Down 0.5%

The company has a debt-to-equity ratio of 0.51, a quick ratio of 1.43 and a current ratio of 1.75. The firm has a 50-day moving average price of $51.11 and a two-hundred day moving average price of $49.80.

Sonova Company Profile

(Get Free Report)

Sonova AG (OTCMKTS:SONVY) is a Switzerland-based provider of hearing care solutions, headquartered in Stäfa. The company designs, develops, manufactures and distributes a range of audiological products and related services aimed at improving hearing and communication for people with hearing loss. Its portfolio spans behind-the-ear and in-the-ear hearing instruments, wireless accessories and software solutions that enable connectivity with consumer devices and audiological fittings.

Sonova markets its products under several well-known brands, including Phonak and Unitron for hearing aids, and it is also associated with Advanced Bionics for cochlear implant systems.

Further Reading

Receive News & Ratings for Sonova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sonova and related companies with MarketBeat.com's FREE daily email newsletter.